Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
Lincoln Park Capital Fund, LLC Invests $1 Million in Provectus Pharmaceuticals
Based in Knoxville Tennessee, Provectus Pharmaceuticals is a company that is developing oncological and dermatological biopharmaceuticals. On December 23, 2010, Provectus has announced that it has entered into a purchase agreement with Chicago-based Lincoln Park Capital Fund, LLC. for a $1 million investment at a premium to the current markets. Lincoln Park has also committed to invest $30 million in equity capital in this promising pharmaceutical company.
As part of the agreement, Lincoln Park Capital has also purchased one million shares in the company. Each share purchased is worth $1.00 and the company and is also committed to purchase another 500,000 shares in Provectus for an additional $1.50 each..
As mentioned above, Provectus’s primary specialty is in developing biopharmaceutical drugs to treat cancer and dermatological ailments and disorders. Currently, Provectus is developing oncological biopharmaceuticals that it advertises on its website as “opening a new front in the war against cancer.” The latest oncology drug that Provectus is developing is the PV-10, which is designed to target the cancer cells in a tumor or other cancerous growth without destroying any of the healthy tissues that are nearby the cancer. This in effect will drastically reduce the number of side affects that most cancer sufferers suffer when they undergo chemotherapy. Some of the oncological focuses that Provectus’s drugs will primarily deal with skin cancers, such as melanoma, as well as other more common cancers, such as breast cancer and metastatic cancers of the liver. On the dermatological front, Provectus is developing a new drug, PH-10, which is supposed to target atopical dermatitis and psoriasis.
According to the CEO of Provectus, Dr. Craig Dees, PhD., the people at Provectus Pharmaceuticals are very pleased with the signing of the purchase agreement with Lincoln Park Capital. Dr. Dees further stated that with this purchase agreement, the company will now have more funds to work with in furthering the clinical studies of both the PV-10 and PH-10 drugs and eventually bringing these drugs up for approval to the FDA.
Some of the other achievements that Provectus can boast of include the arrival of a Slovenian woman who came to St. Luke’s Hospital in Bethlehem, Pennsylvania. As stated on the company’s website, Ms. Madja Rauh, who is a melanoma patient from Ljubljana, Slovenia, has come to St. Luke’s Hospital to take part of Provectus’s compassion program and be a part of the test of the PV-10 drug in treating this type of cancer.
Lincoln Park Capital Fund, LLC , is a Chicago-based private equity firm that has many experienced investment professionals who have experience in the life sciences, energy, and tech industries. Some other companies in Lincoln Park’s portfolio include many different privately and publicly owned companies. Investment criteria include for a prospective company to be able to have strong barriers of entry and niche positions in emerging markets, have products that have the potential to be the top of the class. See the above link to find out more. Investments for private companies typically range from $250,000 to $3 million and for publicly owned companies $1 million to $50 million.
i do enjoy the way you have framed this matter and it does indeed present me personally a lot of fodder for thought. however, because of what i have witnessed, i simply trust when the responses pack on that men and women remain on issue and in no way start on a soap box regarding the news du jour. yet, thank you for this fantastic piece and although i can not agree with this in totality, i regard the perspective.
Great items from you, man. I have have in mind your stuff prior to and you are simply too magnificent. I actually like what you have received here, certainly like what you are saying and the way in which through which you assert it. You are making it entertaining and you still take care of to stay it smart. I cant wait to read much more from you. That is really a wonderful website.
Heya i am for the primary time here. I found this board and I find It truly helpful & it helped me out much. I am hoping to provide something again and help others like you helped me.
I’m not certain where you’re getting your information, but great topic. I needs to spend some time learning much more or figuring out more. Thank you for magnificent information I was looking for this info for my mission.
Excellent items from you, man. I’ve take note your stuff prior to and you’re just extremely fantastic. I really like what you’ve got here, really like what you’re saying and the way in which wherein you are saying it. You are making it enjoyable and you still take care of to stay it wise. I can not wait to read far more from you. That is really a terrific website.
Hello there, I discovered your website by means of Google at the same time as searching for a related subject, your web site came up, it looks good. I’ve added to my favourites|added to bookmarks.
Leave a reply
Friday August 31, 2012
Zscaler Secures $38 Million Investment Round
Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.
Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects
Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding
Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies
Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains
Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster
Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility